Design, synthesis of anticancer and anti-inflammatory 4-(1-methyl-1H-indol-3-yl)-6-(methylthio) pyrimidine-5-carbonitriles

A novel series of 4-(1-methyl-1H-indol-3-yl)-6-(methylthio) pyrimidine-5-carbonitriles (4a-i) was synthesized and evaluated for anticancer potential against cell lines for breast cancer. Compounds 4b, 4e, and 4h exhibited prominent cytotoxicity against human breast carcinoma MCF-7 cell line with GI...

Full description

Saved in:
Bibliographic Details
Published in:Synthetic communications 2022-03, Vol.52 (5), p.733-744
Main Authors: Bhale, Pravin S., Chavan, Hemant V., Shringare, Sadanand N., Khedkar, Vijay M., Tigote, Radhakrishna M., Mali, Nikita N., Jadhav, Tukaram D., Kamble, Nitin B., Kolat, Swati P., Bandgar, Babasaheb P., Patil, Harshal S.
Format: Article
Language:English
Subjects:
Affinity
anti-inflammatory
Anticancer
Anticancer properties
antioxidant
Binding
indole
Kinases
Molecular docking
pyrimidine
Toxicity
Tyrosine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A novel series of 4-(1-methyl-1H-indol-3-yl)-6-(methylthio) pyrimidine-5-carbonitriles (4a-i) was synthesized and evaluated for anticancer potential against cell lines for breast cancer. Compounds 4b, 4e, and 4h exhibited prominent cytotoxicity against human breast carcinoma MCF-7 cell line with GI 50 of 2.0, 0.5, and 0.5 µM, respectively. Molecular docking study against EGFR tyrosine kinase could provide valuable insights into the plausible mechanism of action. The compounds could bind with significantly high binding affinity and their binding affinity scores could correlate well with the observed anticancer activity. Furthermore, compounds 4a, 4c, 4e, 4g, and 4i exhibited significant inflammatory activities as well which could expand the therapeutic domain of this novel series.
ISSN:0039-7911
1532-2432
DOI:10.1080/00397911.2022.2048860